Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Operations (2021 - 2025)

Historic Cash from Operations for P3 Health Partners (PIII) over the last 5 years, with Q3 2025 value amounting to -$15.4 million.

  • P3 Health Partners' Cash from Operations rose 3185.96% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.7 million, marking a year-over-year decrease of 7849.73%. This contributed to the annual value of -$110.1 million for FY2024, which is 4485.19% down from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Cash from Operations is -$15.4 million, which was up 3185.96% from -$16.6 million recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Cash from Operations ranged from a high of -$5.7 million in Q3 2021 and a low of -$57.2 million during Q4 2024
  • In the last 5 years, P3 Health Partners' Cash from Operations had a median value of -$21.0 million in 2022 and averaged -$22.6 million.
  • As far as peak fluctuations go, P3 Health Partners' Cash from Operations crashed by 26830.41% in 2022, and later surged by 6448.93% in 2024.
  • Quarter analysis of 5 years shows P3 Health Partners' Cash from Operations stood at -$11.3 million in 2021, then crashed by 182.74% to -$32.0 million in 2022, then surged by 50.31% to -$15.9 million in 2023, then tumbled by 260.49% to -$57.2 million in 2024, then skyrocketed by 73.07% to -$15.4 million in 2025.
  • Its Cash from Operations stands at -$15.4 million for Q3 2025, versus -$16.6 million for Q2 2025 and -$33.5 million for Q1 2025.